G
Power Law company profile
Galapagos
Biotech & Life Sciences · Mechelen, Belgium · Founded 1999 · IPO 2015 Unicorn
Revenue
$1.22B
Latest reported FY
Global footprint
Where Galapagos has talent and traffic
AI talent share
1.1%
of workforce is AI talent
(9 of 785 staff)
(9 of 785 staff)
Core AI00%
Other AI91.15%
Non-AI workforce77698.85%
Web traffic by country
23K
monthly visits
across markets
across markets
🇺🇸 United States21.7%
🇧🇪 Belgium15.7%
🇳🇱 Netherlands12.2%
🇬🇧 United Kingdom12.2%
🇮🇳 India7.8%
Patent intelligence
$230M patent portfolio · 103 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$230M
2.3× the top peer Celltrion ($101M)
103 active patent families
Where Galapagos innovates
Pharmaceutical drugUreaCarbonyl groupHydrogenCombinatorial chemistry
Below peer median on Legal, Strategic, Economic, Technology
Quality vs same-sector peers
Galapagos on the five Patsnap quality dimensions
Galapagos in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Galapagos concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Galapagos and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Galapagos on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.